Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
|ClinicalTrials.gov Identifier: NCT01516996|
Recruitment Status : Unknown
Verified March 2012 by LANG Jin-yi, The Second People's Hospital of Sichuan.
Recruitment status was: Recruiting
First Posted : January 25, 2012
Last Update Posted : March 20, 2012
The Second People's Hospital of Sichuan
Biotech Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
LANG Jin-yi, The Second People's Hospital of Sichuan
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||September 2013|
|Estimated Study Completion Date :||March 2018|